Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum

Cytokine

Volumn 44, Issue 2, 2008, Pages 275-282

  Lengellé, Juliette ^a   Panopoulos, Evangelos ^a   Betsou, Fotini ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Biobank; Cytokines; Preanalytic variation; Quality control; Serum

Indexed keywords

BIOLOGICAL MARKER; CD40 LIGAND; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 23; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SERINE PROTEINASE INHIBITOR; STROMAL CELL DERIVED FACTOR 1;

ADULT; ARTICLE; BLOOD STORAGE; BODY FLUID; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE;

ADULT; BIOLOGICAL MARKERS; BIOLOGICAL SPECIMEN BANKS; BLOOD PRESERVATION; BLOOD SPECIMEN COLLECTION; BODY FLUIDS; CD40 LIGAND; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 56049101835     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.08.010     Document Type: Article

References (23)

1. ISBER Best Practices for Repositories: Collection, Storage and Retrieval of Biological Materials for Research, 2007 edition.
2. Betsou F., Luzergues A., Carter A., Geary P., Riegman P., Clark B., et al. Marble Arch Working Group on International Biobanking. Towards norms for accreditation of biobanks for human health and medical research: compilation of existing guidelines into an ISO certification/accreditation norm-compatible format. Qual Assur J 11 (2008) 219-292
3. Carraro P., and Plebani M. Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem 53 (2007) 1338-1342
4. NCCLS procedures for the handling and processing of blood specimens; approved guideline. 3rd. NCCLS document H18-A3 [ISBN 1-56238-555-0].
5. Betsou F. Biobanks in immunoanalysis and specialised biology. Immunoanal Biol Spec 21 (2006) 327-332
6. Wahrendorf J., Hanck A.B., Munoz N., Vuilleumier J.P., and Walker A.M. Vitamin measurements in pooled blood samples. Am J Epidemiol 123 (1986) 544-550
7. Bolelli G., Muti P., Micheli A., et al. Validity for epidemiological studies of long-term cryoconservation of steroid and protein hormones in serum and plasma. Cancer Epidemiol Biomarkers Prev 4 (1995) 509-513
8. Paltiel L, Meltzer HM, Hoppin JA, et al. QA/QC in the Norwegian Mother and Child Cohort study-assessment of freeze-thaw cycles on markers in plasma. In: Proceedings of the international society for biological and environmental repositories 2004 meeting, Perugia, Italy, Oct 17-20; 2004:20
9. Chaigneau C., Cabioch T., Beaumont K., and Betsou F. Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation. Clin Chem Lab Med 45 (2007) 1390-1395
10. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
11. Matthews J.N.S., Altman D.G., Campbell M.J., and Royston P. Analysis of serial measurements in medical research. Br Med J 300 (1990) 230-235
12. Banks R.E. Measurement of cytokines in clinical samples using immunoassays: problems and pitfalls. Crit Rev Clin Lab Sci 37 (2000) 131-182
13. Grewal I.S., and Flavell R.A. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16 (1998) 111-135
14. Graf D., Müller S., Korthäuer U., van Kooten C., Weise C., and Kroczek R.A. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 25 (1995) 1749-1754
15. Mazzei G.J., Edgerton M.D., Losberger C., et al. Recombinant soluble trimeric CD40 ligand is biologically active. J Biol Chem 270 (1995) 7025-7028
16. Hsu Y.M., Lucci J., Su L., Ehrenfels B., Garber E., and Thomas D. Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes. J Biol Chem 272 (1997) 911-915
17. Weber M., Rabenau B., Stanisch M., et al. Influence of sample type and storage conditions on soluble CD40 ligand assessment. Clin Chem 52 (2006) 888-891
18. Varo N., Nuzzo R., Natal C., Libby P., and Schonbeck U. Influence of preanalytic and analytical factors on soluble CD40 ligand measurements. Clin Sci (Lond) 111 (2006) 341-347
19. Ahn E.R., Lander G., Jy W., Bidot C.J., Jimenez J.J., Horstman L.L., et al. Differences of soluble CD40 ligand in sera and plasma: implications on CD40 ligand assay as a marker of thrombotic risk. Thromb Res 114 (2004) 143-148
20. Ferrari S., Giliani S., Insalaco A., et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98 (2001) 12614-12619
21. Kornbluth R.S. The emerging role of CD40 ligand in HIV infection. J Leukoc Biol 68 (2000) 373-382
22. Cognasse F., Boussoulade F., Chavarin P., et al. Release of potential immunomodulatory factors during platelet storage. Transfusion 46 (2006) 1184-1189
23. Evans M.J., Livesey J.H., Ellis J.M., and Yandle T.G. Effect of anticoagulants and storage temperature on stability of plasma and serum hormones. Clin Biochem 34 (2001) 109-112